NCT06133322 Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED)
| NCT ID | NCT06133322 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tulane University |
| Condition | Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,176 participants |
| Start Date | 2023-11-01 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,176 participants in total. It began in 2023-11-01 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The burden of hypertension and related cardiovascular diseases, stroke, and end-stage kidney disease is disproportionately high in Black populations, especially in the South. The Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED) cluster randomized trial aims to test the effectiveness, implementation, and sustainability of a community health worker (CHW)-led multifaceted intervention compared to enhanced usual care for hypertension control in Black communities. In the BLESSED trial, the investigators plan to recruit 1,176 adults with hypertension (approximately 28 per church) from 42 predominantly Black churches in the Greater New Orleans area. The multifaceted intervention will last for 18 months, followed by a post-intervention follow-up visit at 24 months. The BLESSED trial aims to generate evidence regarding the effectiveness, implementation, and sustainability of this CHW-led church-based multifaceted intervention in eliminating hypertension disparities in the United States (US) general population.
Eligibility Criteria
Inclusion Criteria: 1. Men or women aged ≥18 years 2. Community members associated with the participating churches (church members and their families and friends) 3. Systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥80 mm Hg 4. Willing and able to participate in the intervention. 5. Willing and able to sign written informed consent. Exclusion Criteria: 1. Prior hospitalization in the last 3 months for chronic heart failure or heart attack 2. Current diagnosis of cancer requiring chemotherapy or radiation therapy 3. Stage-5 chronic kidney disease requiring chronic dialysis or transplant 4. Pregnant or planning to become pregnant in the next 18 months 5. Planning to move out of the Greater New Orleans area during the next year
Frequently Asked Questions
Who can join the NCT06133322 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06133322 currently recruiting?
Yes, NCT06133322 is actively recruiting participants. Visit ClinicalTrials.gov or contact Tulane University to inquire about joining.
Where is the NCT06133322 trial being conducted?
This trial is being conducted at New Orleans, United States.
Who is sponsoring the NCT06133322 clinical trial?
NCT06133322 is sponsored by Tulane University. The trial plans to enroll 1,176 participants.